These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12176580)

  • 1. Cyclosporine does not influence serum cholesterol in kidney transplant recipients.
    Matzkies FK; Keuthage W; Kobelt V; Hillebrand U; Gerhardt U; Suwelack B; Hohage H
    Transplant Proc; 2002 Aug; 34(5):1795-6. PubMed ID: 12176580
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of Neoral on plasma cholesterol concentration in renal transplant recipients.
    Konstadinidou I; Boletis JN; Chelioti H; Avdikou K; Theodoropoulou H; Gounari P; Kostakis A; Stathakis CP
    Transplant Proc; 2001 May; 33(3):2393-4. PubMed ID: 11377572
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.
    Wilczek HE; Akesson P; Warholm C
    Transplant Proc; 1998 Aug; 30(5):1753-5. PubMed ID: 9723267
    [No Abstract]   [Full Text] [Related]  

  • 4. Histopathological findings of 10-year protocol biopsy in pediatric kidney transplant recipients.
    Kamimaki I; Shishido S; Ikeda M; Honda M
    Transplant Proc; 2002 Dec; 34(8):3130-1. PubMed ID: 12493397
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between maintenance dose of cyclosporine and long-term kidney graft survival. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1998 Aug; 30(5):1716-7. PubMed ID: 9723253
    [No Abstract]   [Full Text] [Related]  

  • 6. A trial of oral magnesium supplementation in renal transplant recipients receiving cyclosporine.
    Nguyen T; Steiner RW
    Transplant Proc; 1998 Dec; 30(8):4317-9. PubMed ID: 9865371
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
    Mizuno Y; Kikuchi H; Fujimori K; Doi H; Orii T; Ohkohchi N; Satomi S
    Transplant Proc; 2000 Nov; 32(7):1677-8. PubMed ID: 11119888
    [No Abstract]   [Full Text] [Related]  

  • 8. High performance liquid chromatography cyclosporine monitoring: a predictor of renal graft outcome.
    Cicciarelli J; Avila D; Iwaki Y; Sather H; Mendez R
    Transplant Proc; 1998 Aug; 30(5):1683-4. PubMed ID: 9723243
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index.
    Hortal L; Fernández A; Losada A; Lorenzo M; Baamonde E; Plaza C; Gallego R; Vega N; Palop L
    Transplant Proc; 2001; 33(7-8):3110-1. PubMed ID: 11750337
    [No Abstract]   [Full Text] [Related]  

  • 10. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A.
    Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M
    Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636
    [No Abstract]   [Full Text] [Related]  

  • 11. Measurement of lymphocyte cyclosporine levels in transplant patients.
    Masri MA; Barbari A; Stephan A; Rizk S; Kilany H; Kamel G
    Transplant Proc; 1998 Nov; 30(7):3561-2. PubMed ID: 9838559
    [No Abstract]   [Full Text] [Related]  

  • 12. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice.
    Vathsala A; Lu YM
    Transplant Proc; 2001; 33(7-8):3137-9. PubMed ID: 11750348
    [No Abstract]   [Full Text] [Related]  

  • 13. Early cyclosporine concentration as predictor of graft survival in cadaveric renal transplantation.
    Salmela K; Kyllönen L
    Transplant Proc; 2001 Jun; 33(4):2441-3. PubMed ID: 11406202
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of trough level and C(2) cyclosporine blood concentration monitoring in outpatient kidney transplant recipients.
    Braun F; Armstrong VW; Lorf T; Canelo R; Arndt C; Oellerich M; Ringe B
    Transplant Proc; 2001; 33(7-8):3108-9. PubMed ID: 11750336
    [No Abstract]   [Full Text] [Related]  

  • 15. Area under the curve of Neoral and chronic use of mycophenolate mofetil.
    Rial M; Guardia O; Greco G; Argento J; Casadei D
    Transplant Proc; 1998 Jun; 30(4):1195-6. PubMed ID: 9636484
    [No Abstract]   [Full Text] [Related]  

  • 16. Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe.
    Citterio F; Di Pinto A; Borzi MT; Scatà MC; Foco M; Pozzetto U; Castagneto M
    Transplant Proc; 2001 May; 33(3):2134-5. PubMed ID: 11377476
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of kidney functions and cyclosporine levels in renal transplant patients on Panimum Bioral in post transplant period.
    Sharma DR; Singh S
    J Indian Med Assoc; 1999 May; 97(5):204-5. PubMed ID: 10652891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicardipine on blood cyclosporine levels in renal transplant patients.
    Guan D; Wang R; Lu J; Wang M; Xu C
    Transplant Proc; 1996 Jun; 28(3):1311-2. PubMed ID: 8658673
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-transplant hyperlipidemia: risk factors and response to dietary modification and gemfibrozil therapy.
    Bastani B; Robinson S; Heisler T; Puntney G; Aridge D; Lindsey L; Solomon H; Garvin PJ
    Clin Transplant; 1995 Aug; 9(4):340-8. PubMed ID: 7579744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients.
    Varghese Z; Abudher MN; Fernando ON; Moorhead JF
    Transplant Proc; 2001 May; 33(3):2251-3. PubMed ID: 11377518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.